Anticancer agent 175

• Target:

  Apoptosis|||Reactive Oxygen Species

• Related Pathways:

  Metabolism|||Apoptosis|||Immunology/Inflammation|||NF-?B

• Bioactivity:

  Anticanceragent 175 (complex 1) is a near-infrared luminescent therapeutic compound. It induces ROS accumulation, mitochondrial damage, disruption of the Bax/Bcl-2 balance, and apoptosis (apoptosis) in HepG2 cell lines.

• Molecular Formula:

  C81H86F10IrN8O4P-

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C